Pharmaceutical Pricing and Reimbursement Europe - Reference Pricing and Si bi13280526 NEW YORK, Nov. 9, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report available catalogue: Pricing and Reimbursement Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to..

Research and Markets: Pharmaceutical Pricing, Reimbursement, and Market Acces bi13280526 DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4e0c7f/_pri) has announced the addition of Decision Resources, Inc.'s new report " Pricing, Reimbursement, and Market Access News the Second Quarter of 2011" to offering. In the second quarter of 2011, several governments major markets announced plans ..

KV Pharmaceutical Sued Over Pregnancy Drug Pricing Statements bi13280526 KV Co. (KV/A) was sued by an investor who accused of misleading shareholders about marketing plans for Makena, a drug intended to prevent premature births

New drug pricing policy to pinch top three firms bi13280526 Revenue loss estimated at Rs 1,200 crore, says study

Settlement shines light on 'nominal pricing' bi13280526 GlaxoSmithKline's settlement over "nominal pricing" practices the US reflects a long-running dispute between regulators and many companies over handling of drug reimbursement ..

iMANY Helps Global Pharmaceutical Companies Successfully Manage the Operation bi13280526 PHILADELPHIA, PA-- - iMANY , the leading provider of contract performance solutions , announced today that three of the world's largest companies have implemented the iMANY® 340B Compliance ..

The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 bi13280526 Reportlinker.com announces that a new market research report available catalogue:..

Investors sue KV Pharmaceutical, alleging misleading statements bi13280526 A proposed class action lawsuit against KV Co. alleges the drugmaker misled investors positive public statements about pregnancy drug Makena ? just before KV stock tanked earlier year

Pharmaceutical Pricing and Reimbursement Europe - Reference Pricing and Si bi13280526 NEW YORK, Nov. 9, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report available catalogue: Pricing and Reimbursement Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to..

Research and Markets: Pharmaceutical Pricing, Reimbursement, and Market Acces bi13280526 DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4e0c7f/_pri) has announced the addition of Decision Resources, Inc.'s new report " Pricing, Reimbursement, and Market Access News the Second Quarter of 2011" to offering. In the second quarter of 2011, several governments major markets announced plans ..

KV Pharmaceutical Sued Over Pregnancy Drug Pricing Statements bi13280526 KV Co. (KV/A) was sued by an investor who accused of misleading shareholders about marketing plans for Makena, a drug intended to prevent premature births

New drug pricing policy to pinch top three firms bi13280526 Revenue loss estimated at Rs 1,200 crore, says study

Settlement shines light on 'nominal pricing' bi13280526 GlaxoSmithKline's settlement over "nominal pricing" practices the US reflects a long-running dispute between regulators and many companies over handling of drug reimbursement ..

Ps2 Backup Software - Home